James Gage
Chief Science Officer
Clinical Sciences
Asymchem
China
Biography
As the Chief Science Officer for Asymchem, Dr. Gage is the head of R&D, technology development and strategic planning. Dr. Gage has 24 years of experience in process chemistry and other aspects of pharmaceutical CMC. Prior to joining Asymchem in early 2006, Dr. Gage worked from 1991-2005 at Pfizer and Pfizer legacy companies in roles of increasing scientific and managerial responsibility, supporting programs from preclinical development to commercial life-cycle management and both domestic and foreign manufacturing facilities. He maintains an active interest in the application of new technologies to problems in drug substance and drug product manufacturing for increased control and reduced cost. He is an author in over 30 research papers, patents, and meeting presentations. And he is the member of American Chemical Society. Born in Chicago, Dr. Gage earned a B.S. in Chemistry from Calvin College and his Ph.D. in Chemistry with Professor David Evans at Harvard University in 1991.As the Chief Science Officer for Asymchem, Dr. Gage is the head of R&D, technology development and strategic planning. Dr. Gage has 24 years of experience in process chemistry and other aspects of pharmaceutical CMC. Prior to joining Asymchem in early 2006, Dr. Gage worked from 1991-2005 at Pfizer and Pfizer legacy companies in roles of increasing scientific and managerial responsibility, supporting programs from preclinical development to commercial life-cycle management and both domestic and foreign manufacturing facilities. He maintains an active interest in the application of new technologies to problems in drug substance and drug product manufacturing for increased control and reduced cost. He is an author in over 30 research papers, patents, and meeting presentations. And he is the member of American Chemical Society. Born in Chicago, Dr. Gage earned a B.S. in Chemistry from Calvin College and his Ph.D. in Chemistry with Professor David Evans at Harvard University in 1991.
Research Interest
Clinical data management, Clinical trails, Pharmacovigilance
